Skip to main navigation

Careers    |    Contact    |    News    |       

  • About Arbutus
    • Overview
    • Management
    • Our Board
    • Scientific Advisory Board
    • Careers
  • About HBV
    • HBV Background
    • HBV Science
    • The Baruch S. Blumberg Institute
  • >
  • R&D Portfolio
    • HBV Assets
      • AB-729 (GalNAc-RNAi)
      • AB-836 (Capsid Inhibitor)
      • HBV RNA Destabilizers
    • Partnered Programs
      • Genevant
      • Gritstone
      • ONPATTRO™ (patisiran)
      • Marqibo ®
  • Partners
    • Partnering & Licensing
    • LNP Collaborations & Partners
    • HBV Collaborators & Partners
  • Investors
    • Investor Center
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Investor FAQ
    • Contact Us

Investor Relations

  • Investor Center
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Investor FAQ
  • Contact Us

Download Library

Title Type
  • Add Files
    2008 Annual Report 586.8 KB
  • Add Files
    2008 Annual Report 586.8 KB

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
Displaying 41 - 41 of 41 results

Shareholder Tools

  • Email Alerts Email Alerts
  • RSS News Feeds RSS News Feeds
  • Download Library Download Library

© 2021 Arbutus Biopharma

Legal Terms